These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25637041)

  • 1. Role of non-invasive imaging in the work-up of cardiomyopathies.
    Tummala LS; Young RK; Singh T; Jani S; Srichai MB
    Curr Atheroscler Rep; 2015 Mar; 17(3):486. PubMed ID: 25637041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to differentiate the etiology of LV dysfunction as to whether it is "ischemic cardiomyopathy" or "dilated non-ischemic cardiomyopathy"? Invasive coronary and myocardial assessment is the approach of first choice.
    Ahn SG; Samady H
    J Nucl Cardiol; 2015 Oct; 22(5):953-6. PubMed ID: 26153258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Imaging techniques in heart failure].
    Martínez Dolz L; Almenar Bonet L
    Rev Esp Cardiol; 2006 Jul; 6 Suppl F():27-45. PubMed ID: 17144975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac magnetic resonance imaging for stage B heart failure.
    Partington SL; Cheng S; Lima JA
    Heart Fail Clin; 2012 Apr; 8(2):179-90. PubMed ID: 22405659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cardiac MR Imaging in Cardiomyopathies.
    Kramer CM
    J Nucl Med; 2015 Jun; 56 Suppl 4(0 4):39S-45S. PubMed ID: 26033902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance.
    Schuster A; Morton G; Chiribiri A; Perera D; Vanoverschelde JL; Nagel E
    J Am Coll Cardiol; 2012 Jan; 59(4):359-70. PubMed ID: 22261158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance imaging of non-ischaemic cardiomyopathy.
    Deshpande A; Pakkal M; Agrawal B; Raj V
    Postgrad Med J; 2012 Jan; 88(1035):38-48. PubMed ID: 21725033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.
    Gonzalez JA; Kramer CM
    Curr Heart Fail Rep; 2015 Aug; 12(4):276-83. PubMed ID: 26041670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Non-invasive Imaging Techniques in Chronic Heart Failure and Cardiomyopathies : Focus on Cardiac Magnetic Resonance Imaging and Computed Tomographic.
    Di Bella G; Pizzino F; Donato R; Di Nunzio D; de Gregorio C
    Adv Exp Med Biol; 2018; 1067():183-196. PubMed ID: 29498024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification for ventricular arrhythmias in ischaemic cardiomyopathy: the value of non-invasive imaging.
    de Haan S; Knaapen P; Beek AM; de Cock CC; Lammertsma AA; van Rossum AC; Allaart CP
    Europace; 2010 Apr; 12(4):468-74. PubMed ID: 20338987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
    Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
    Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.
    Renz DM; Röttgen R; Habedank D; Wagner M; Böttcher J; Pfeil A; Dietz R; Kivelitz D; Elgeti T
    Rofo; 2011 Sep; 183(9):834-41. PubMed ID: 21830182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies.
    Motwani M; Kidambi A; Greenwood JP; Plein S
    Heart; 2014 Nov; 100(21):1722-33. PubMed ID: 24694798
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse diseases of the myocardium: MRI-pathologic review of nondilated cardiomyopathies.
    Giesbrandt KJ; Bolan CW; Shapiro BP; Edwards WD; Mergo PJ
    AJR Am J Roentgenol; 2013 Mar; 200(3):W266-73. PubMed ID: 23436871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of determining the viability of the myocardium prior to revascularisation in patients with ischaemic cardiomyopathy and left ventricular systolic dysfunction].
    Hutyra M; Skála T; Kamínek M; Horák D; Lukl J
    Vnitr Lek; 2008 Apr; 54(4):395-401. PubMed ID: 18630619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction.
    Her SH; Yoon HJ; Lee JM; Jin SW; Youn HJ; Seung KB; Kim JH
    Clin Nucl Med; 2008 Jul; 33(7):459-63. PubMed ID: 18580229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac magnetic resonance tomography in the diagnostics of restrictive and unclassified cardiopathies].
    Kramer U; May AE; Mangold S; Krumm P; Claussen CD
    Radiologe; 2013 Jan; 53(1):45-53. PubMed ID: 23160570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.